|
Beurs gesloten -
Nasdaq
22:00:00 02-09-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 556,75 USD | +1,66% |
|
+1,73% | +22,81% |
| 02/09 | Vertex Pharmaceuticals Incorporated : Evercore ISI bevestigt koopadvies | ZM |
| 01/09 | Vertex Pharmaceuticals benoemt Jonathan Poole tot Executive Vice President met ingang van 1 januari 2027 | CI |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1,66% | +1,73% | +16,69% | +30,97% | +22,81% | +38,84% | +58,57% | +179,46% | +485,37% | 141 mld. | ||
| +0,01% | -2,47% | +0,98% | +9,01% | +7,95% | +57,79% | +108,23% | +346,92% | +1.409,54% | 1.034 mld. | ||
| +1,48% | +1,93% | +7,36% | +23,47% | +32,98% | +54,56% | +71,49% | +57,33% | +130,65% | 663 mld. | ||
| +0,67% | -0,45% | +4,30% | +21,50% | +14,54% | +23,50% | +76,60% | +133,64% | +308,17% | 462 mld. | ||
| +2,08% | -1,76% | +0,45% | +14,76% | +8,96% | +32,69% | +38,79% | -1,96% | +47,10% | 344 mld. | ||
| -0,31% | +5,09% | +5,20% | +15,38% | +19,51% | +27,07% | +47,12% | +57,11% | +68,03% | 307 mld. | ||
| +1,53% | +0,63% | +6,00% | -7,72% | -11,60% | -0,16% | +14,03% | +43,26% | +148,62% | 251 mld. | ||
| +1,08% | +0,57% | +14,98% | +34,91% | +35,30% | +54,34% | +72,51% | +95,98% | +160,85% | 239 mld. | ||
| +1,89% | +4,20% | +1,77% | +13,19% | -5,41% | -15,63% | -53,06% | -2,27% | +100,23% | 207 mld. | ||
| -0,21% | +1,03% | +14,90% | +17,28% | +21,89% | +32,74% | +95,19% | +106,82% | +94,58% | 186 mld. | ||
| +1,65% | +2,54% | +16,03% | +13,58% | +16,55% | +16,17% | -18,89% | -38,04% | -16,54% | 165 mld. | ||
| +1,11% | +0,13% | +3,60% | +24,24% | +25,44% | +42,71% | +9,09% | +2,33% | +20,07% | 138 mld. | ||
| -0,13% | -0,23% | +3,49% | +4,87% | -6,79% | -10,47% | -21,35% | -12,24% | +10,16% | 107 mld. | ||
| +1,20% | +2,02% | -1,05% | +2,05% | +3,56% | +28,76% | +37,56% | +2,22% | -8,08% | 101 mld. | ||
| +0,67% | -0,99% | +2,86% | -7,34% | -16,56% | +6,73% | +54,88% | +55,89% | +497,22% | 70,85 mld. | ||
| +1,44% | +1,70% | +9,25% | +24,43% | +22,19% | +31,32% | +30,33% | +58,60% | +24,22% | 58,62 mld. | ||
| -0,38% | +0,93% | +3,84% | +41,01% | +32,21% | +74,53% | -3,38% | +3,06% | -48,08% | 56,01 mld. | ||
| -1,43% | -2,50% | -15,74% | -5,85% | -23,50% | -33,83% | +9,73% | -0,63% | +175,93% | 44,63 mld. | ||
| -1,61% | -2,08% | -0,14% | +12,64% | -3,47% | -2,40% | +14,60% | - | - | 43,54 mld. | ||
| +3,59% | -1,13% | +7,08% | +13,33% | +20,12% | +99,95% | +281,00% | +293,80% | -26,81% | 43,69 mld. | ||
| Gemiddelde | +0,58% | -0,89% | +5,09% | +14,79% | +10,83% | +27,96% | +46,15% | +72,70% | +188,49% | 233,17 mld. | |
| Gewogen gemiddelde per kap. | +0,73% | -0,76% | +5,19% | +15,39% | +13,96% | +35,86% | +59,36% | +122,79% | +421,52% |
- Beurs
- Aandelen
- Koers VRTX
- Sector Vertex Pharmaceuticals Incorporated
Kies jouw editie
Alle financiële informatie op nationaal niveau
















